Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy
- PMID: 37137726
- PMCID: PMC10574814
- DOI: 10.1212/WNL.0000000000207470
Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy
Erratum for
-
Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.Neurology. 2023 Apr 4;100(14):687-688. doi: 10.1212/WNL.0000000000207209. Neurology. 2023. PMID: 37012062 Free PMC article. No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources